Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Healthcare Biotechnology
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Anytime now
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(36)
•••
Comment by TankRebel2012on Mar 26, 2020 2:08pm
140 Views
Post# 30850238

RE:RE:RE:RE:RE:RE:Anytime now

RE:RE:RE:RE:RE:RE:Anytime now
tankingfrank wrote: i dont know if amnioboost will work, should have an idea in a few weeks. 50-100 mkt cap is possible. 


you should follow the company twitter account.  Enough info by them to show good future results.

https://twitter.com/LatticeBio


"Coronavirus China: Potential stem cell injections breakthrough"
https://www.dailymail.co.uk/news/article-8116881/Doctor-claims-breakthrough-stem-cell-injections-treat-coronavirus.html







https://www.businessinsider.com/coronavirus-recovery-damage-lung-function-gasping-air-hong-kong-doctors-2020-3

"Some people who recover from the coronavirus might be left with '20 to 30%' less lung function, and gasping for breath when they walk quickly, Hong Kong doctors said "
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities